ADAR1 Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.2M | Buy |
582,147
+191,418
| +49% | +$6.32M | 2.95% | 8 |
|
|
2025
Q1 | $15.7M | Sell |
390,729
-23,480
| -6% | -$944K | 2.92% | 6 |
|
|
2024
Q4 | $19.5M | Sell |
414,209
-496,973
| -55% | -$23.4M | 3.89% | 6 |
|
|
2024
Q3 | $48.1M | Buy |
911,182
+57,320
| +7% | +$3.03M | 7.82% | 1 |
|
|
2024
Q2 | $46.3M | Buy |
853,862
+534,352
| +167% | +$29M | 8.73% | 2 |
|
|
2024
Q1 | $22.4M | Buy |
319,510
+227,428
| +247% | +$15.9M | 5.08% | 5 |
|
|
2023
Q4 | $7.69M | Buy |
+92,082
| New | +$7.69M | 2.75% | 5 |
|